Hospital Clinic-IDIBAPS, University of Barcelona, HIV Unit, Barcelona, Spain; CIBER of infectious Diseases (CIBERINFEC), Madrid, Spain.
Hospital Clinic-IDIBAPS, University of Barcelona, HIV Unit, Barcelona, Spain.
Lancet HIV. 2023 Jan;10(1):e42-e51. doi: 10.1016/S2352-3018(22)00302-2. Epub 2022 Oct 27.
Although antiretroviral therapy (ART) is effective in suppressing viral replication, HIV-1 persists in reservoirs and rebounds after ART has been stopped. However, a very few people (eg, elite and post-treatment controllers) are able to maintain viral loads below detection limits without ART, constituting a realistic model for long-term HIV remission. Here, we describe the HIV control mechanisms of an individual who showed exceptional post-treatment control for longer than 15 years.
We report the case of a Hispanic woman aged 59 years with sexually acquired acute HIV infection, who was included in an immune-mediated primary HIV infection trial involving a short course of ciclosporine A, interleukin-2, granulocyte macrophage colony-stimulating factor, and pegylated interferon alfa, followed by analytical treatment interruption. We did the following viral assays: total and integrated HIV-1 DNA in CD4 T cells and rectal tissue, quantitative viral outgrowth assay, HIV-1 infectivity in peripheral blood mononuclear cells and CD4 T-cell cultures and viral inhibitory activity by natural killer (NK) and CD8 T cells. NK and T-cell phenotypes were determined by flow cytometry. HLA, killer cell immunoglobulin-like receptors, Δ32CCR5, and NKG2C alleles were genotyped.
After ART and immunomodulatory treatment, the person maintained undetectable plasma viral load for 15 years. HIV-1 subtype was CFR_02AG, CCR5-tropic. We found progressive reductions in viral reservoir during the 15-year treatment interruption: total HIV DNA (from 4573·50 copies per 10 CD4 T cells to 95·33 copies per 10 CD4 T cells) and integrated DNA (from 85·37 copies per 10 CD4 T cells to 5·25 copies per 10 CD4 T cells). Viral inhibition assays showed strong inhibition of in vitro HIV replication in co-cultures of CD4 T cells with autologous NK or CD8 T cells at 1:2 ratio (75% and 62%, respectively). Co-cultures with NK and CD8 T cells resulted in 93% inhibition. We detected higher-than-reference levels of both NKG2C-memory-like NK cells (46·2%) and NKG2C γδ T cells (64·9%) associated with HIV-1 control.
We described long-term remission in a woman aged 59 years who was treated during primary HIV infection and has maintained undetectable viral load for 15 years without ART. Replication-competent HIV-1 was isolated. NKG2C-memory-like NK cells and γδ T cells were associated with the control viral replication. Strategies promoting these cells could bring about long-term HIV remission.
Fondo Europeo para el Desarrollo Regional (FEDER), SPANISH AIDS Research Network (RIS), Fondo de Investigación Sanitaria (FIS), HIVACAT, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), CERCA Programme/Generalitat de Catalunya, la Caixa Foundation, and Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC).
For the Spanish translation of the abstract see Supplementary Materials section.
尽管抗逆转录病毒疗法(ART)可有效抑制病毒复制,但 HIV-1 仍存在于储库中,并在停止 ART 后反弹。然而,极少数人(例如精英和治疗后控制者)能够在没有 ART 的情况下将病毒载量维持在检测限以下,这构成了长期 HIV 缓解的现实模型。在这里,我们描述了一名个体的 HIV 控制机制,该个体在超过 15 年的时间内表现出异常的治疗后控制。
我们报告了一名 59 岁西班牙裔女性的病例,她患有性传播的急性 HIV 感染,她参与了一项免疫介导的原发性 HIV 感染试验,包括短期环孢素 A、白细胞介素-2、粒细胞巨噬细胞集落刺激因子和聚乙二醇化干扰素 alfa 治疗,随后进行了分析性治疗中断。我们进行了以下病毒检测:CD4 T 细胞和直肠组织中的总和整合 HIV-1 DNA、定量病毒外生测定、外周血单核细胞和 CD4 T 细胞培养物中的 HIV-1 感染性以及自然杀伤(NK)和 CD8 T 细胞的病毒抑制活性。通过流式细胞术确定 NK 和 T 细胞表型。鉴定了 HLA、杀伤细胞免疫球蛋白样受体、Δ32CCR5 和 NKG2C 等位基因。
在 ART 和免疫调节治疗后,该人在 15 年内保持了无法检测到的血浆病毒载量。HIV-1 亚型为 CFR_02AG,CCR5 嗜性。我们发现,在 15 年的治疗中断期间,病毒库逐渐减少:总 HIV DNA(从每 10 CD4 T 细胞 4573.50 个拷贝减少到每 10 CD4 T 细胞 95.33 个拷贝)和整合 DNA(从每 10 CD4 T 细胞 85.37 个拷贝减少到每 10 CD4 T 细胞 5.25 个拷贝)。体外 HIV 复制抑制试验显示,在 CD4 T 细胞与自体 NK 或 CD8 T 细胞的共培养物中,HIV 复制分别得到 75%和 62%的强烈抑制。与 NK 和 CD8 T 细胞的共培养导致 93%的抑制。我们检测到与 HIV-1 控制相关的 NKG2C 记忆样 NK 细胞(46.2%)和 NKG2C γδ T 细胞(64.9%)的水平高于参考值。
我们描述了一名 59 岁女性的长期缓解情况,该女性在原发性 HIV 感染期间接受了治疗,并在 15 年内未接受 ART 治疗而保持了无法检测到的病毒载量。分离出了具有复制能力的 HIV-1。NKG2C 记忆样 NK 细胞和 γδ T 细胞与控制病毒复制有关。促进这些细胞的策略可能会带来长期的 HIV 缓解。
欧洲区域发展基金(FEDER)、西班牙艾滋病研究网络(RIS)、西班牙卫生研究基金(FIS)、HIVACAT、巴塞罗那艾滋病研究所(IDIBAPS)、CERC 计划/加泰罗尼亚政府、La Caixa 基金会和传染病研究生物医学网络(CIBERINFEC)。